|
18.12.2014 19:04:06
|
Esperite N.V. appoints EY as external auditor
Esperite N.V. (Euronext: ESP, 'Esperite', or 'the Group'), the European leader in stem cells cryopreservation, now entering the fields of predictive medicine and translational regenerative medicine R&D, announces that all resolutions of today's extra-ordinary general meeting of shareholders ("EGM") were passed and that EY Accountants LLP was appointed as external auditor for a term of 1-year
| Enquiries: Esperite: | + 31 (0) 575 548 998 |
| Frédéric Amar, Chief Executive Officer |
About Esperite (www.esperite.com)
Esperite, the leading international company in regenerative and predictive medicine. Its family stem cell bank, CryoSave, stores almost 275,000 samples from umbilical cord blood and cord tissue. There are already many diseases treatable by the use of stem cells, and the number of treatments will only increase. Esperite has cryopreserved samples from over 70 countries on six continents, with ultra-modern processing and storage facilities in Belgium, Switzerland, Germany, Dubai, South Africa and Portugal.
This announcement is distributed by Nasdaq OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Esperite N.V. via Globenewswire
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Esperite N.V. via Globenewswire
HUG#1881600
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Esperitemehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Esperitemehr Analysen
Aktien in diesem Artikel
| Esperite | 0,04 | 0,00% |
|
Letzte Top-Ranking Nachrichten
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.